Weiguo Zhai Settles SEC Insider Trading Charges Over Icosavax Stock
Former AstraZeneca director Weiguo Zhai agreed to pay $21,547 to settle SEC insider trading charges tied to Icosavax stock.
Weiguo Zhai Settles SEC Insider Trading Charges Over Icosavax Stock Read More »
